Study Summary
A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma.
Want to learn more about this trial?
Request More InfoInterventions
Humanized CD19 CAR-T cellsDRUG
Each subject receive humanized CD19 CAR T-cells by intravenous infusion
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The First Affiliated Hospital，College of Medicine, Zhejiang University | Hangzhou | Zhejiang | China |